<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND
AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
(Amendment No. 1)*
Crown Castle International Corporation
-----------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
-----------------------------------------------------
(Title of Class of Securities)
228227104
-------------------------------
(CUSIP Number)
Tami E. Nason, Esq. COPY TO: Larry J. Rowe, Esq.
Charlesbank Capital Ropes & Gray
Partners, LLC One International Place
600 Atlantic Avenue Boston, MA 02110
Boston, MA 02210 (617) 951-7407
(617) 619-5400
----------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
March 9, 1999 - January 18, 2000
----------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e) 13-d1(f) or 13d-1(g), check the following box
[_].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
________________
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
SCHEDULE 13D
- ----------------------- ---------------------
CUSIP No. 228227104 Page 2 of 8 Pages
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1. S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Harvard Private Capital Holdings, Inc.
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2. (a) [X]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3.
- ------------------------------------------------------------------------------
SOURCE OF FUNDS*
4.
WC
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
5.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6.
Massachusetts
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7.
NUMBER OF
0 Shares
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8.
................
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9.
REPORTING 0 Shares
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10.
................
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11.
0 Shares
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12.
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.
0%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14.
CO
- ------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
- ----------------------- ---------------------
CUSIP No. 228227104 Page 3 of 8 Pages
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1. S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Charlesbank Capital Partners, LLC
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2. (a) [X]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3.
- ------------------------------------------------------------------------------
SOURCE OF FUNDS*
4.
WC
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [_]
5.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6.
Massachusetts
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7.
NUMBER OF
0 Shares
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8.
................
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9.
REPORTING
0 Shares
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10.
................
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11.
0 Shares
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12.
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.
0%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14.
OO
- ------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
------------
Crown Castle International Corporation
Amendment No. 1
---------------
Introductory Statement
This Amendment No. 1 hereby amends the initial Schedule 13D filed on
September 1, 1998 (the "Initial Schedule 13D"). This Amendment No. 1 relates to
the Common Stock, $.01 par value per share (the "Shares") of Crown Castle
International Corp., a Delaware corporation (the "Company"). This amendment is
filed by Harvard Private Capital Holdings, Inc. ("Harvard Private Capital") and
Charlesbank Capital Partners, LLC ("Charlesbank").
This Amendment No. 1 amends Items 2, 5 and 6 with respect to information
concerning Harvard Private Capital and Charlesbank in the initial Schedule 13D
filed by Digital Future Investments, B.V.; TeleDiffusion de France International
S.A.; TeleDiffusion de France; France Telecom; Candover Investments plc;
Candover (Trustees) Limited; Candover Partners Limited (as general partner of
the Candover 1994 UK Limited Partnership, the Candover 1994 UK No. 2 Limited
Partnership, the Candover 1994 US No. 1 Limited Partnership and the Candover
1994 US No. 2 Limited Partnership); Candover Services Limited; Ted B. Miller,
Jr.; the Miller 1996 Gift Trust; Robert A. Crown (individually and for the
Robert A. Crown grantor retained annuity trust); Barbara A. Crown (individually
and for the Barbara A. Crown grantor retained annuity trust); Berkshire Fund
III, A Limited Partnership; Third Berkshire Associates Limited Partnership;
Berkshire Fund IV, Limited Partnership; Fourth Berkshire Associates LLC;
Berkshire Investors LLC; Centennial IV; Holding IV; Centennial V; Entrepreneurs
V; Holdings V; Nassau Capital Partners II, L.P.; Nassau Capital LLC; NAS
Partners I, L.L.C.; Fay, Richwhite Communications Limited; PNC Venture Corp.;
PNC Holdings Corp.; PNC Bank Corp.; American Home Assurance Company; The
Northwestern Mutual Life Insurance Company; Harvard Private Capital Holdings,
Inc.; Charlesbank Capital Partners, LLC; Prime VIII, L.P. and Prime SKA I,
L.L.C. Neither Harvard Private Capital nor Charlesbank assumes responsibility
for the completeness or accuracy of the information contained in the Initial
Schedule 13D or any amendment to the Initial Schedule 13D concerning any other
person.
Item 2. Identity and Background.
-----------------------
Item 2 is hereby amended in its entirety to read as follows:
Harvard Private Capital is a Massachusetts corporation with its principal
office located c/o Charlesbank Capital Partners, LLC, at 600 Atlantic Avenue,
Boston, MA 02210. Harvard Private Capital is a charitable company holding a
portion of the endowment fund of Harvard University. Harvard Private Capital is
controlled by the President and Fellows of Harvard College, a Massachusetts
educational corporation and title-holding company for the endowment fund of
Harvard University.
Page 4 of 8 Pages
<PAGE>
The Directors of Harvard Private Capital, all of whom are citizens of the
United States of America, and whose principal business address is located at 600
Atlantic Avenue, Boston MA 02210, are Michael R. Eisenson, Tim R. Palmer, and
Jack R. Meyer. The Officers of Harvard Private Capital, all of whom are citizens
of the United States of America, and whose principal business address is located
at 600 Atlantic Avenue, Boston, MA 02210, are Michael R. Eisenson (President),
Mark A. Rosen (Vice President), Tim R. Palmer (Vice President), Stephen
McSweeney (Treasurer), Tami E. Nason (Clerk), and Michael Thonis (Assistant
Clerk).
Charlesbank is a Massachusetts limited liability company which acts as an
investment manager to President and Fellows of Harvard College and certain other
entities. The principal executive offices of Charlesbank are located at 600
Atlantic Avenue, 26th Floor, Boston, MA 02210. Subject to the terms of the
Stockholders Agreement (described in Item 6 of the Initial Schedule 13D),
Charlesbank, pursuant to an agreement among Charlesbank, the President and
Fellows of Harvard College and certain individuals, has sole power to direct the
vote on the Shares of which Harvard Private Capital is the beneficial owner.
The Managing Members of Charlesbank, all of whom are citizens of the United
States of America, and whose principal business address is c/o Charlesbank
Capital Partners, LLC, 600 Atlantic Avenue, 26th Floor, Boston, MA 02210, are
Michael R. Eisenson, (President and Chief Executive Officer), Mary Lou Boutell
(Managing Director), Kim G. Davis (Managing Director), William P. Douglas
(Managing Director), Tim R. Palmer (Managing Director), Mark A. Rosen (Managing
Director), Michael Thonis (Chief Financial Officer and Managing Director), and
Charles F. Wu (Managing Director).
Item 5. Interest in Securities of the Issuer.
------------------------------------
Item 5 is hereby amended in its entirety to read as follows:
(a) Harvard Private Capital: 0 Shares of the Company (0% of class)
Charlesbank: 0 Shares of the Company (0% of class)
Pursuant to the terms of the Stockholders Agreement (described in Item 6 of
the Initial Schedule 13D), Harvard Private Capital has ceased to be a party to
the Stockholders Agreement as a result of the sale of all of the Shares
previously held by Harvard Private Capital.
(b) Number of Shares as to which Harvard Private Capital has sole power to vote
or direct the vote, shared power to vote or direct the vote, sole or shared
power to dispose or to direct the disposition: 0 Shares.
Number of Shares as to which Charlesbank has sole power to vote or direct
the vote, shared power to vote or direct the vote, sole or shared power to
dispose or to direct the disposition: 0 Shares.
Page 5 of 8 Pages
<PAGE>
(c) Between March 9, 1999 and November 9, 1999, Harvard Private Capital sold
2,164,745 Shares of the Company. The transaction dates, number of shares sold
and prices per share during that period are as follows:
<TABLE>
<CAPTION>
Date of Transaction Shares Sold Price Per Share
------------------- ----------- ---------------
<S> <C> <C>
3/9/99 42,500 $20.50
3/16/99 5,000 $20.00
4/13/99 10,000 $18.25
4/14/99 20,000 $18.25
9/7/99 100,000 $18.84
9/8/99 85,000 $19.16
9/9/99 140,000 $19.15
9/10/99 175,000 $19.24
9/13/99 100,000 $19.18
9/15/99 80,000 $19.95
9/16/99 80,000 $19.58
9/17/99 37,000 $19.50
9/20/99 87,000 $19.53
9/22/99 22,000 $19.00
9/23/99 30,000 $20.06
9/24/99 10,000 $19.50
9/30/99 54,000 $18.50
10/4/99 108,000 $18.84
10/5/99 28,000 $18.19
10/6/99 82,000 $18.50
10/7/99 50,000 $18.60
10/12/99 6,000 $18.75
10/22/99 18,000 $18.50
10/26/99 15,000 $19.00
10/28/99 179,000 $19.69
10/29/99 40,000 $19.99
11/1/99 132,000 $19.61
11/2/99 50,000 $19.63
11/5/99 200,000 $18.53
11/8/99 37,000 $22.00
11/9/99 142,245 $22.27
</TABLE>
Transactions from March 9, 1999 through October 29, 1999 were pursuant to
Rule 144 under the Securities Act of 1933, as amended. All transactions from
November 1, 1999 through November 9, 1999 were open-market transactions.
On January 5, 2000, Harvard Private Capital converted its warrant to
purchase 299,000 Shares of the Company into 213,245 Shares of the Company
following a cashless exercise of such warrant. Between January 13, 2000 and
January 18, 2000, Harvard Private Capital sold 213,245 Shares of the Company.
The transaction dates, number of shares sold and prices per share are as
follows:
Page 6 of 8 Pages
<PAGE>
<TABLE>
<CAPTION>
Date of Transaction Shares Sold Price Per Share
------------------- ----------- ---------------
<S> <C> <C>
1/13/00 50,000 $30.01
1/14/00 60,000 $29.55
1/18/00 103,245 $29.99
</TABLE>
All of the above transactions were open-market transactions.
By virtue of the relationships reported under Item 2, Charlesbank may be
deemed to have sold all of its beneficially owned Shares at the time that
Harvard Private Capital sold the Shares described above.
Except for the transactions described above, neither Harvard Private
Capital nor Charlesbank has engaged in any transactions in the Shares of the
Company during the past 60 days. To the best of Harvard Private Capital's and
Charlesbank's knowledge and belief, none of the directors or executive officers
of Harvard Private Capital or managing members of Charlesbank has engaged in any
transactions in the Shares of the Company during the past 60 days.
(d) Not applicable.
(e) This statement is being filed to report the fact that as of January 18,
2000, Harvard Private Capital and Charlesbank ceased to be the beneficial owners
of any Shares of the Company.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect
---------------------------------------------------------------------
to Securities of the Issuer.
---------------------------
Pursuant to the terms of the Stockholders Agreement (described in Item 6 of
the Initial Schedule 13D), Harvard Private Capital has ceased to be a party to
the Stockholders Agreement as a result of the sale of all of the Shares
previously held by Harvard Private Capital.
Page 7 of 8 Pages
<PAGE>
Signature
---------
After reasonable inquiry and to the best of their knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: February 7, 2000
HARVARD PRIVATE CAPITAL HOLDINGS, INC.
By: /s/ Tami E. Nason
-----------------------------
Name: Tami E. Nason
Title: Authorized Signatory
CHARLESBANK CAPITAL PARTNERS, LLC
By: /s/ Tami E. Nason
-----------------------------
Name: Tami E. Nason
Title: Vice President, Legal
Page 8 of 8 Pages
